Tenax Therapeutics Statistics

Total Valuation

TENX has a market cap or net worth of $16.77 million. The enterprise value is -$81.78 million.

Market Cap	16.77M
Enterprise Value	-81.78M

Important Dates

The last earnings date was Wednesday, November 13, 2024, before market open.

Earnings Date	Nov 13, 2024
Ex-Dividend Date	n/a

Share Statistics

TENX has 3.41 million shares outstanding. The number of shares has increased by 3,389.71% in one year.

Current Share Class	3.41M
Shares Outstanding	3.41M
Shares Change (YoY)	+3,389.71%
Shares Change (QoQ)	+980.62%
Owned by Insiders (%)	0.24%
Owned by Institutions (%)	25.91%
Float	2.64M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.17
P/TBV Ratio	0.17
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 38.95

Current Ratio	38.95
Quick Ratio	38.38
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-606.59

Financial Efficiency

Return on equity (ROE) is -26.84% and return on invested capital (ROIC) is -17.87%.

Return on Equity (ROE)	-26.84%
Return on Assets (ROA)	-17.39%
Return on Capital (ROIC)	-17.87%
Revenue Per Employee	n/a
Profits Per Employee	-$2.43M
Employee Count	6
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -82.95% in the last 52 weeks. The beta is 2.15, so TENX's price volatility has been higher than the market average.

Beta (5Y)	2.15
52-Week Price Change	-82.95%
50-Day Moving Average	4.11
200-Day Moving Average	3.81
Relative Strength Index (RSI)	62.07
Average Volume (20 Days)	55,871

Short Selling Information

The latest short interest is 105,757, so 3.10% of the outstanding shares have been sold short.

Short Interest	105,757
Short Previous Month	21,026
Short % of Shares Out	3.10%
Short % of Float	4.00%
Short Ratio (days to cover)	1.46

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.54M
Pretax Income	-10.10M
Net Income	-14.56M
EBITDA	-15.53M
EBIT	-15.54M
Earnings Per Share (EPS)	-$2.32

Full Income Statement

Balance Sheet

Cash & Cash Equivalents	98.31M
Total Debt	n/a
Net Cash	98.31M
Net Cash Per Share	$28.84
Equity (Book Value)	97.22M
Book Value Per Share	28.52
Working Capital	97.22M

Full Balance Sheet

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TENX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3,389.71%
Shareholder Yield	-3,389.71%
Earnings Yield	-90.49%
FCF Yield	n/a

Analyst Forecast

The average price target for TENX is $20.67, which is 320.12% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.67
Price Target Difference	320.12%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on January 3, 2024. It was a reverse split with a ratio of 0.0125:1.

Last Split Date	Jan 3, 2024
Split Type	Reverse
Split Ratio	0.0125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1